| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |